Accès ouvert
2025
conference-abstract
OpenAlex
Kirstin Barnhart, Brad N. Bolon, Laura I. Boone, Stacey L. Fossey et autres
The 2025 Town Hall meeting of the Society of Toxicologic Pathology (STP) discussed virtual control groups (VCG) in nonclinical toxicity testing, which are being pursued by multiple organizations to reduce animal use in product development. The current VCG literature infrequently reflects the …
us, ch, ca
(code pays fourni par la source)
2025
article
OpenAlex
Magali Guffroy, Tara Arndt, Erio Barale-Thomas, Susan Bolin et autres
Nonhuman primates (NHPs) have been and remain a highly valuable animal model with an essential role in translational research and pharmaceutical drug development. Based on current regulatory guidelines, the nonclinical safety of novel therapeutics should be evaluated in relevant nonclinical species, which …
us, be, br, ch
(code pays fourni par la source)
2024
article
OpenAlex
Xavier Palazzi, Lennart T Anger, Theresa Boulineau, Armelle Grevot et autres
us, jp, fr, ch, gb, de
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Kenji Namoto, Clara Baader, Vanessa Orsini, Alexandro Landshammer et autres
ch, de, us, mx, gb
(code pays fourni par la source)
2023
article
OpenAlex
Armelle Grevot, Julie Boisclair, Magali Guffroy, Peter Hall et autres
In the last decade, numerous initiatives have emerged worldwide to reduce the use of animals in drug development, including more recently the introduction of Virtual Control Groups (VCGs) concept for nonclinical toxicity studies. Although replacement of concurrent controls (CCs) by virtual controls …
ch, us, de, gb, be
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Emily Golden, David F. Allen, Alexander Amberg, Lennart T. Anger et autres
Historical data from control groups in animal toxicity studies are currently mainly used for comparative purposes to assess validity and robustness of study results. Due to the highly controlled environment in which the studies are performed and the homogeneity of the animal …
us, de, ch
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Emilie A. Chapeau, Agnieszka Gembarska, Éric Durand, Emeline Mandon et autres
Significance Emergence of resistance to targeted therapy constitutes a limitation to long-term clinical benefits in many instances. To anticipate potential mechanisms of resistance to double minute 2 protein (MDM2) inhibitors, we performed a piggyBac insertional mutagenesis screen in a cohort of allografts …
ch, de
(code pays fourni par la source)
2015
article
OpenAlex
Jens Schümann, Armelle Grevot, David Ledieu, Armin Wolf et autres
Sphingosine-1-phosphate (S1P) lyase is considered as a drug target in autoimmune diseases based on the protective effect of reducing activity of the enzyme in animal models of inflammation. Since S1P lyase deficiency in mice causes a severe, lethal phenotype, it was of …
ch
(code pays fourni par la source)
Accès ouvert
2013
article
OpenAlex
Caterina Vacchi‐Suzzi, Florian Hahne, Philippe Scheubel, Magali Marcellin et autres
MicroRNAs are short non-coding RNAs that regulate gene expression at the post-transcriptional level and play key roles in heart development and cardiovascular diseases. Here, we have characterized the expression and distribution of microRNAs across eight cardiac structures (left and right ventricles, apex, …
ch, us
(code pays fourni par la source)
Accès ouvert
2011
article
OpenAlex
Martin C. Herzig, Carine Kolly, Elke Persohn, Diethilde J Theil et autres
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's disease (PD), but the underlying pathophysiological mechanisms and the normal function of this large multidomain protein remain speculative. To address the role of this protein in vivo, we generated three different LRRK2 …
ch, us
(code pays fourni par la source)
Accès ouvert
2011
article
OpenAlex
Ellena J. Growcott, Alan Coulthard, Richard T. Amison, Elizabeth L. Hardaker et autres
gb, us, ch
(code pays fourni par la source)